Mad proteins are basic ± helix ± loop ± helix ± leucine zipper (bHLH-ZIP)-containing members of the myc oncoprotein network. They interact with the bHLH-ZIP protein max, compete for the same DNA binding sites as myc-max heterodimers and down-regulate mycresponsive genes. Using the bHLH-ZIP domain of mad1 as a yeast two-hybrid`bait', we identi®ed Mmip-2, a novel RING ®nger protein that interacts with all mad members, but weakly or not at all with c-myc, max or unrelated bHLH or bZIP proteins. The mad1-Mmip-2 interaction is mediated by the ZIP domain in the former protein and by at least two regions in the latter which do not include the RING ®nger. Mmip-2 can disrupt maxmad DNA binding and can reverse the suppressive eects of mad proteins on c-myc-responsive target genes and on c-myc+ras-mediated focus formation in ®broblasts. Tagging with spectral variants of green¯uorescent protein showed that Mmip-2 and mad proteins reside in separate cytoplasmic and nuclear compartments, respectively. When co-expressed, however, the proteins interact and translocate to the cellular compartment occupied by the more abundant protein. These observations suggest a novel way by which Mmip-2 can modulate the transcriptional activity of myc oncoproteins.
Introduction
Transcriptional regulation by members of the myc oncoprotein network is mediated, both directly and indirectly, by a variety of protein ± protein interactions (Henriksson and Luscher, 1996; Facchini and Penn, 1998; . The central participant is max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) , an extremely stable and ubiquitously expressed bHLH-ZIP protein that can associate with all three major myc proteins (c-myc, Nmyc, and L-myc) to form heterodimers with high anity for the consensus`myc box sequence' CAC/ TGTG found in many myc-responsive genes (Blackwood et al., 1992; Blackwell et al., 1993; Ma et al., 1993; Prochownik and VanAntwerp, 1993; Henriksson and Luscher, 1996; Facchini and Penn, 1998; Dang, 1999) . Target gene activation is then mediated by a transcriptional activation domain (TAD) present in the aminoterminus of each myc member (Kato et al., 1990; Barrett et al., 1992) . c-myc is expressed primarily in proliferating cells, is extremely labile, and is strongly down-regulated in response to growth arrest or terminal dierentiation (Lachman and Skoultchi, 1984; St. Arnaud et al., 1988; DePinho et al., 1991; Evan and Littlewood, 1993; Henriksson and Luscher, 1996; Zhang et al., 1997; Dang, 1999) . The expression of Nmyc and L-myc is highly tissue-restricted, particularly in the adult animal (Zimmerman et al., 1986) . Therefore, a signi®cant amount of the positive transcriptional regulation of myc-responsive genes that occurs in vivo is the result of¯uctuations in myc protein levels or dierential tissue expression of myc family proteins.
Negative regulation of myc-responsive genes is mediated by a dierent arm of the myc network that involves heterodimerization between max and at least four related bHLH-ZIP proteins referred to as the mad family Zervos et al., 1993 Zervos et al., , 1994 Hurlin et al., 1995a; . Each mad member (mad1, mxi1, mad3, and mad4) shows distinct patterns of tissue-and differentiation-speci®c expression (Larsson et al., 1994; Hurlin et al., 1995b; Queva et al., 1998) . Mad protein expression tends to correlate inversely with that of cmyc, being induced during terminal dierentiation and repressed during active proliferation and in undifferentiated cells and tissues (Larsson et al., 1994; Hurlin et al., 1995a,b; Vastrik et al., 1995; Queva et al., 1998) . It is believed that mad-max heterodimers compete with myc-max heterodimers for the same DNA binding sites and repress transcription through an active process involving the recruitment by mad of a non-bHLH-ZIP co-repressor, mSin3, as well as other proteins, including a histone deacetylase (Lahoz et al., 1994; Schreiber-Agus et al., 1995; Ayer et al., 1995; Hassig et al., 1997; Laherty et al., 1997; . The interaction with mSin3 requires a highly conserved region, termed the SID domain, found at the extreme amino termini of all mad members (Ayer et al., 1995; Schreiber-Agus et al., 1995; .
The need to exert rigid control over myc oncoproteins is illustrated by the biological consequences of their aberrant expression, which may be a primary defect in many human cancers (Nesbit et al., 1999) . More recently, it has been shown that mad1 or mxi1 nullizygous mice show developmental abnormalities, are predisposed to spontaneous or experimentally induced neoplasms, and manifest growth and restorative abnormalities of primary cells in vitro .
In addition to the above interactions, which all occur via bHLH-ZIP domains, a number of associations between myc and non-bHLH-ZIP proteins have been characterized (reviewed in Facchini and Penn, 1998) . Bin1, p107, and TRRAP are three unrelated proteins which interact with the TAD of c-myc and modulate its activity (Beijersbergen et al., 1994; Gu et al., 1994; Sakamuro et al., 1996; McMahon et al., 1998) . Several non bHLH-ZIP proteins which interact with the bHLH-ZIP region of c-myc have also been described and include AP-2, and two zinc-®nger proteins, Miz1 and YY-1 (Shrivastava et al., 1993 (Shrivastava et al., , 1996 Gaubatz et al., 1995; Peukert et al., 1997) . At least two non bHLH-ZIP proteins have been characterized which interact with one or more mad family members. mSin3 has been shown to be important for mad proteins to repress myc-responsive genes (Ayer et al., 1995; Schreiber-Agus et al., 1995; . More recently, we have described a novel ZIP only-containing protein, Mmip-1 (`mad member-interacting protein-1'), that interacts with the ZIP domains of all four mad members (Gupta et al., 1998) . Overexpression of Mmip1 reverses the suppressive eects of mad proteins on promoters containing both arti®cial and naturallyoccurring myc binding sites. Thus, normal function and regulation of the myc network, in addition to requiring`classic' bHLH-ZIP associations, is likely to involve non-bHLH-ZIP interactions as well (Facchini and Penn, 1998) .
Because of the importance of mad proteins in the control of myc oncoprotein function, we have continued to search for new mad-interacting partners. We report here the cloning and characterization of a novel RING ®nger-containing protein, Mmip-2. Together with our previous characterization of Mmip-1 (Gupta et al., 1998) , our ®ndings suggest the existence of multiple proteins, of diverse structure, whose function it is to modify max-mad interactions and thus indirectly to in¯uence myc oncoprotein transcriptional activity. Our ®nding that Mmip-2 can alter the subcellular location of mad proteins suggests a novel mechanism by which myc transcriptional activity can be regulated.
Results

Cloning and characterization of Mmip-2
To identify proteins which interacted with mad1, we expressed its bHLH-ZIP domain in yeast as a Gal4 DNA binding domain fusion in the pGBT9 vector. The protein did not self-transactivate but interacted strongly with a Gal4-max fusion protein (Table 1,  lines 2 and 4) .
Yeast harboring the pGBT-9-mad1 vector were transformed with a d.11 mouse embryo cDNA library. A total of 4610 6 colonies were plated onto SC plates lacking his, leu, and trp and containing 30 mM 3-aminotriazole. Approximately 50 histidine prototrophs were identi®ed and, of these, three tested very strongly in an in situ b-galactosidase assay. We designated the cDNA as`mad member interacting protein-2' (Mmip-2) (see Gupta et al., 1998 for the cloning and characterization of Mmip-1).
We initially de®ned the interactions between Mmip-2 and other members of the myc network, as well as several other unrelated proteins (Table 1) . Yeast expressing the original pGAD-Mmip-2 isolate were transformed with pGBT9 vectors encoding c-myc, max, mad1, mad3, mad4, as well as with the empty pGBT9 vector alone. As seen in Table 1 (lines 1, 2, 6, 9, 12, 15, 18, 22 and 26) , neither the pGAD-Mmip-2`prey' nor any of the`baits' was able to self-transactivate the bgalactosidase reporter gene. A strong interaction was Table 1 Interaction between Mmip-2 and myc network members. Yeast transformants expressing each of the indicated pGBT9`baits' were selected as individual Trp prototrophs. Single colonies were grown, retransformed with the indicated pGAD vectors, and selected for Trp+Leu prototrophy. Five to ten individual double transformants were streaked onto EGG plates and allowed to grow for an additional 2 ± 3 days prior to performing in situ b-galactosidase assays as previously described Gupta et al., 1998 Because the original`bait' vector contained only the bHLH-ZIP domain of mad1, it was evident that this region was both necessary and sucient for the Mmip-2 interaction. However, we have previously shown that only the ZIP domain of mad proteins is required for their interaction with Mmip-1, a ZIP-containing protein (Gupta et al., 1998) . Therefore, we created two additional pGBT9-mad1 constructs which eliminated portions of either the HLH or ZIP domains so as to render them incapable of interacting with max ( 
In vitro interactions mirror those seen in yeast
To con®rm the in vivo interactions seen in yeast, the original Mmip-2 cDNA was excised from its pGAD10 vector and expressed as a GST fusion protein in the pGEX-4T vector. GST-Mmip-2, or GST alone, was puri®ed by standard glutathione-agarose anity chromatography and tested in`pulldown' experiments with 35 S-methionine labeled in vitro translated members of the myc network. As seen in Figure 1 , GST-Mmip-2 interacted quantitatively with 35 S-mad1, mad3 and mad4. A variable but consistently low level of interaction was seen with mxi1 whereas no detectable interaction was seen with either max or c-myc. We conclude that, in general, the in vitro interactions mirrored those seen in vivo (Table 1 ).
Figure 1`GST pulldown' experiments. The original Mmip-2 cDNA isolate (encoding amino acids 2 ± 301, see Figure 2 ) was expressed as a GST fusion protein and puri®ed by glutathione-agarose anity chromatography. GST-Mmip-2 or GST alone were then incubated with the indicated 35 S-labeled full-length myc network proteins as previously described (Gupta et al., 1998) , precipitated by the addition of glutathione-agarose, washed extensively, and resolved by SDS ± PAGE. In the rightmost lane of each panel, an aliquot of 35 S-labeled protein, equivalent to that used for each GST pulldown, was electrophoresed in parallel to serve as a denominator for the eciency of GST or GST-Mmip-2 capture
Complete coding sequence of Mmip-2 Sequencing of the original Mmip-2 cDNA in the pGAD10 vector revealed an 898 nt insert, in-frame over its entire length with the Gal4 TAD. This suggested that our original cDNA clone did not encode a full-length protein. We therefore screened approximately 10 6 cDNA clones from a Friend murine erythroleukemia cDNA library. Several positive clones were identi®ed and sequenced. The complete coding sequence of Mmip-2, compiled from overlapping cDNAs, is shown in Figure 2 . Of note is that the longest composite cDNA is 1098 nt in length and encodes an open reading frame for a 316 amino acid protein. Upstream of the putative initiation codon at position 127, the 5'-untranslated region contains numerous translation termination codons in all three reading frames. The termination codon at nt 1076 is followed by a short, 21 nt 3'-untranslated region with no evidence of a polyadenylation signal. The original Mmip-2 cDNA isolate begins at nt 132, ends at nt 1030 and thus encodes all but 16 amino acids of the fulllength protein. SDS ± PAGE of the products of a coupled in vitro transcription/translation reaction showed a single band of M r =37 kDa, in excellent agreement with the calculated 35.7 kDa size of the fulllength conceptual translation product (not shown).
Although searches of GenBank indicated that Mmip-2 encoded a unique protein, several signi®cant features were identi®ed. Most notably, we observed that amino acids 33 ± 75 (Figure 2a underlined) encode a domain that is in perfect agreement with the previously determined consensus sequence for a RING ®nger: C-X 2 -C-X (9 ± 39) -C-X (1 ± 3) -H-X (2 ± 3) -C-X2-C-X (4 ± 48) -C-X 2 -C (Fremont, 1993; Saurin et al., 1996) . The Nterminal region of this element contains a calciumcalmodulin-dependent kinase II phosphorylation site (RKVSV: amino acids 38 ± 42) whereas the C-terminal half (amino acids 52 ± 76) bears homology (50% identity; 67% similarity) to a previously cloned RING ®nger-containing protein that interacts with the cytoplasmic domain of CD40/FAS (Hu et al., 1994) . Amino acids 204 ± 303 encode a region with distant homology to murine Type II cytoskeletal keratin (26% identity and 71% similarity) (Figure 2b ). A cluster of consensus N-glycosylation sites (NXS/T) is found at amino acids 110, 135, and 138. Finally, since Mmip-2 contains no additional zinc ®nger domains, it does not appear to be a member of the`RBCC' or`TRAF' subgroup of RING ®nger proteins (Saurin et al., 1996) .
Tissue expression of Mmip-2
To determine the size of the endogenous Mmip-2 transcript, we performed a Northern blot on total RNA puri®ed from NIH3T3 ®broblasts and Friend murine erythroleukemia cells. This showed the presence of a single, ca. 4.5 kb transcript that was expressed at a higher level in the latter cell type (Figure 3a) . To determine the tissue distribution of Mmip2, we hybridized the same cDNA probe to a`Mouse RNA Master Blot' (Clontech) that contains poly(A) + RNA derived from 18 adult tissues and total embryos of four dierent gestational ages. As seen in Figure 3c , Mmip-2 was expressed at the highest level in adult testis and at signi®cantly lower but detectable levels in the adult thyroid, submaxillary gland, ovary, and epididymis. The lack of detectable transcript in any of the whole embryo RNAs was consistent with its restricted expression in adult tissues.
The Mmip-2 RING ®nger is not necessary for interaction with mad1
Having established that the ZIP domain of mad1 was essential for its interaction with Mmip-2, we performed the converse experiment. A series of amino terminal and carboxy terminal deletions of Mmip-2 were generated, expressed as fusion proteins in pGAD10, and tested for interaction with the mad1 fusion protein originally used to conduct the yeast two hybrid screen. As described previously, the fusion protein encoded by the original Mmip-2 cDNA isolate (amino acids 2 ± 301) interacted strongly with mad1 ( Figure 5 , line 2). An amino-terminal deletion which removed an additional 42 residues, including a large segment of the RING ®nger, interacted with the mad1 bait as strongly as the original isolate ( Figure 5 , line 3). The removal of an additional 88 amino acids, including all of the RING ®nger resulted in a considerable, although incomplete, loss of interaction ( Figure 5 , line 4), From these deletions, we conclude that the RING ®nger domain is largely, if not entirely, dispensable for the mad1 interaction. Rather, the region between amino acids 44 ± 132 is primarily responsible for the association.
Deletions of the C-terminus further revealed a second region in Mmip-2 required for its interaction with mad1. As seen in Figure 5 (line 6), the removal of 52 amino acids from the C-terminus resulted in a total loss of interaction with mad1. Further deletions ( Figure 5 , lines 7 ± 9) also failed to interact. From these and the foregoing observations, we can conclude that Mmip-2 requires at least two distinct regions for its interaction with mad1, and presumably with all other mad members. One region localizes just downstream of the RING ®nger in the N-terminal portion of the molecule whereas another localizes to the extreme C-terminus.
In vitro functional consequences of Mmip-2 and mad protein interactions
The observation that, both in yeast and in`GSTpulldown'-type experiments, Mmip-2 bound each of the four known mad proteins but not c-myc, max, or several unrelated bHLH or bZIP proteins, not only indicated that these interactions were speci®c, but that they may also have functional signi®cance. To determine whether this was indeed the case, we expressed mad1, mxi1, mad4, and max as hexahistidine fusion proteins in E. coli and puri®ed each to near homogeneity (Prochownik and VanAntwerp, 1993; Zhang et al., 1997; Yin et al., 1998) . Using a 32 P-end-labeled oligonucleotide containing a consensus c-myc binding site in an electrophoretic mobility shift assay (EMSA), we then asked whether the addition of GST-Mmip-2 could inhibit DNA binding by madmax heterodimers or max-max homodimers. To eliminate any ambiguity due to similarities in the appearance of shifted complexes that contained both max and mad member proteins, we used only the shorter, 151 amino acid isoform of max [max(S)] which, as we have previously shown, binds DNA very + RNAs from a variety of adult tissues and total embryos of four dierent gestational ages was hybridized with the Mmip-2 cDNA probe from (a). Tissues examined included brain (a1), eye (a2), liver (a3), lung (a4), kidney (a5), heart (b1), skeletal muscle (b2), smooth muscle (b3), pancreas (c1), thyroid (c2), thymus (c3), submaxillary gland (c4), spleen (c5), testis (d1), ovary (d2), prostate (d3), epididymis (d4), uterus ( d5), day 7 embryo (e1), day11 embryo (e2), day 15 embryo (e3), day 17 embryo (e4), yeast total RNA (f1), yeast tRNA (f2), E. coli rRNA (f3), E. coli DNA (f4), poly r(A) (g1), Cot1 DNA (g2), mouse DNA (g3 and g4). Mmip-2 expression was detected at highest level in testis (d1), and at lower levels in thyroid (c2), submaxillary gland (c4), ovary (d2), and epididymis (d4) Figure 4 Deletion analysis of Mmip-2. The indicated deletions were generated by standard PCR-based techniques using primers with engineered 5'-EcoRI and 3'-BamHI sites to allow for directional cloning into the pGAD10 vector. Each deletion mutant was then introduced into yeast along with either pGBT9 alone or the pGBT9-mad1 construct used as the original two-hybrid bait. 5 ± 10 leucine+tryptophan prototrophs were randomly selected, grown for 2 ± 3 days on EGG plates and tested for b-galactosidase production using an in situ ®lter assay as previously described Gupta et al., 1998) . The scoring system for bgalactosidase expression was as described in the legend to Table 1 poorly as a homodimer (Prochownik and VanAntwerp, 1993; Zhang et al., 1997) . To test the eect of Mmip-2 on DNA binding by max, we used the 160 amino acid isoform [max(L)] of the latter protein which binds DNA4100-fold more strongly than max(S) (Zhang et al., 1997) . As seen in Figure 5a ± c (lanes 2 ± 4), neither max(S) nor any of the individual mad member proteins bound signi®cant amounts of the input probe. On the other hand, as we and others have previously shown Zervos et al., 1993; Hurlin et al., 1995a; Gupta et al., 1998) , the combination of max(S) and any mad protein resulted in strong DNA binding (Figure 5a ± c, lanes 5). In all three cases, the addition of puri®ed GST-Mmip-2 resulted in a progressive loss of DNA binding whereas the addition of GST alone had no eect. In several experiments performed with mad1 and mad4, loss of DNA binding was ®rst detected with 25 ± 50 ng of GST-Mmip-2 and was almost completely abolished with 100 ng (Figure 5a,c) . In contrast, nearly twice as much GST-Mmip2 was required to reverse the DNA binding of mxi1-max heterodimers (Figure 5b ). This agreed well with our other observations (Table 1 and Figure 1 ) that the interaction between Mmip-2 and mxi1 was the weakest of all the mad family members.
In contrast to the eects that GST-Mmip-2 exerted on DNA binding by mad-max heterodimers, the protein had no eect on DNA binding by max(L) homodimers. Although some loss of DNA binding was occasionally seen when 4300 ng of GST-Mmip-2 was added, similar results were obtained with control GST protein (not shown) that we attribute to a non-speci®c eect. Thus our ®ndings are consistent with the idea Figure 5 Electrophoretic mobility shift assays. All members of the myc network were expressed as hexahistidine-tagged proteins in E. coli and puri®ed to near homogeneity by nickel-agarose anity chromatography (Prochownik and VanAntwerp, 1993) . Approximately 20 ng was used in each EMSA reaction. GST and GST-Mmip-2 were puri®ed as described in the legend to Figure 1 and added at the indicated amounts. After a 20 min incubation at 408C to allow for dimer formation, approximately 0.1 ng of the 32 P-labeled EO(GAC) c-myc binding site oligonucleotide plus 1 mg of poly(dI) : (dC) were added for an additional 20 min incubation followed by 4% non-denaturing polyacrylamide gel electrophoresis in 16TBE buer as previously described (Prochownik and VanAntwerp, 1993; Zhang et al., 1997; Gupta et al., 1998) that Mmip-2 exerts a speci®c inhibitory eect on DNA binding by mad-max heterodimers.
In vivo interactions between Mmip-2 and mad proteins
To determine whether Mmip-2 and mad 1 were capable of interacting in vivo, we performed a mammalian twohybrid assay (Finkel et al., 1993; Anand et al., 1997; . The plasmid pSG424-Mmip-2 was created to allow the expression of Mmip-2 as a Gal4 DNA binding domain fusion protein. Similarly, the plasmid pNLVP was used to create two fusion proteins between the VP-16 transactivation domain and either mad1 or mxi1. Based on the data presented above, we predicted that the Gal4-Mmip-2 prey should interact more strongly with the VP16-mad1 bait than with the VP16-mxi1 bait. As a positive control for a strong interaction, we measured the association between cdk4 and cyclinD1 . As seen in Figure 6 , neither pSG424 nor pVLVP16 alone, or together with the cognate mad1, mxi1, or Mmip-2 fusion vectors, resulted in the production of more than background amounts of CAT activity. In contrast, the combination of pSG424-Mmip-2 and pNLVP-mad1 generated a signi®cant amount of CAT activity . Much lower, but still signi®cant, amounts of CAT activity were seen with the pNLVP-mxi1 vector, thus con®rming the relatively weak association between mxi1 and Mmip-2.
As an independent means of assessing the ability of Mmip-2 to interact with mad family members, we determined its ability to reverse the previously described suppressive eects of mad proteins on a cmyc responsive reporter gene Zervos et al., 1993; Hurlin et al., 1995a; Gupta et al., 1998) . Expression vectors containing the complete coding region of each relevant cDNA were co-transfected into NIH3T3 cells along with a reporter construct containing the c-myc-responsive ornithine decarboxylase (ODC) promoter juxtaposed to a CAT gene (Packham and Cleveland, 1994 ). As we have previously shown (Zhang et al., 1997; Yin et al., 1998) , the expression of c-myc resulted in a 4 ± 8-fold upregulation of the ODC promoter (Figure 7 ). Concurrent expression of any one of the four mad members resulted in a strong suppression of the cmyc eect to baseline levels or below (Gupta et al., 1998) . This was completely reversed in a dosedependent manner, however, by co-expression of Mmip-2. As had been seen in our other assays (Figures 1, 5 and 6 ), Mmip-2 was less eective in reversing the eect of mxi1 than of other mad members. Similar results were observed with an arti®cial promoter (p3xMycE1b-luciferase, Gupta et al., 1993) (not shown).
As a ®nal means of assessing the ability of Mmip-2 to reverse the inhibitory eects of mad proteins, we performed rat embryo ®broblast transformation assays with c-myc and activated ras expression plasmids. As previously demonstrated (Gupta et al., 1998) , none of the individual myc network proteins, Mmip-2, or ras alone produced transformed foci (Figure 8 , columns 1 ± 6). As expected, the combination of c-myc+ras expression plasmids produced a high level of focus formation that was almost entirely inhibited by the concurrent expression of either mad1, mxi1, or mad3 (Figure 8 , compare column 7 with columns 9 ± 11). In the case of mad1 and mad3, complete rescue of focusforming ability was seen when Mmip-2 was coexpressed ( Figure 8, columns 12 and 14) . Although rescue of focus-forming ability was also seen in the case of mxi1, the eect was partial (Figure 8 , column 13) and did not change signi®cantly when larger amounts of the Mmip-2 expression vector were used (not shown). Mmip-2 by itself produced a small enhancement of c-myc+ras focus formation ( Figure  8, column 8 ). This probably re¯ects the minor contribution of endogenous mad proteins to modulating exogenously supplied c-myc function.
In situ interaction between Mmip-2 and mad proteins results in changes in subcellular distribution
To determine the subcellular distribution of Mmip-2, we expressed it as a fusion protein with a variant form of green¯uorescent protein (GFP`Topaz') and transiently expressed it in NIH3T3 ®broblasts. Exam- . Three mg of pCMV-b-Gal (Clontech) was added to each precipitate to allow normalization of transfection eciencies. Two days later cells were lysed and assayed for b-galactosidase and CAT activities as previously described. CAT conversion over background was determined by phosphorImage analysis. Values shown represent the average of three independent experiments, each performed in duplicate plates +1 standard error (s.e.) ination by epi¯uorescence microscopy of either live or ®xed cells showed virtually all the Topaz-Mmip-2 protein to be concentrated in an average of three (range 1 ± 5) large, well circumscribed juxtanuclear foci per cell (Figure 9c) . Observations of several hundred cells showed that Topaz-Mmip-2 never localized to the nucleus.
Because mad proteins are thought to be con®ned to the nucleus (Ayer and Eisenman, 1993; Schreiber-Agus and DePinho, 1998), it was initially unclear how they might be able to interact with Mmip-2. To investigate this in more detail, we created another fusion protein between mad3 and a dierent spectral variant of GFP (GFP`Sapphire'). GFP-Sapphire and GFP-Topaz can be distinguished from one another by dierences in their excitation/emission maxima (Figure 9a ± d) . As expected, Sapphire-mad3 was always localized to the nucleus in a distinct punctate pattern (Figure 9a ). Each transfection was performed by a standard calcium phosphate-based procedure and pCMVb-gal was included in each precipitate to allow normalization of transfection eciencies. Two days later, cells were harvested and assayed for bgalactosidase and CAT as previously described. The results shown represent the average of three independent experiments, each performed in duplicate+1 s.e.
We next co-transfected the two GFP vectors at various ratios to determine whether interactions between Mmip-2 and mad3 might in¯uence their distribution. When co-expressed at a 1 : 1 molar ratio, little change in their respective subcellular localization patterns was seen (Figure 9e,f) . This segregated pattern was seen in 480% of the cells which expressed both proteins. A much dierent pattern was seen at a 1 : 5 molar ratio of Topaz-Mmip-2 to Sapphire-mad3. Under these conditions, virtually all the TopazMmip-2 protein entered the nucleus and retained its distinctive appearance (Figure 9h) .
Conversely, when the plasmid ratios were reversed (Topaz-Mmip-2:Sapphire-mad3=5 : 1), most of the Sapphire-mad3 protein left the nucleus and colocalized with Mmip-2 in the previously described juxtanuclear foci (Figure 9j ± l) Thus, although mad3 (and presumably other mad members) and Mmip-2 are con®ned to distinct subcellular regions, they are capable, under appropriate conditions, of in¯uencing one another's location in a co-dominant and dynamic manner. This pattern was seen in 490% of cells expressing both proteins at the above described unequal ratios. Similar experiments performed in either Rat1a cells or Cos7 cells gave identical results (not shown). In other experiments, we have shown an identical co-dominant interaction between Mmip-2 and mad1 as well as the anticipated much weaker interaction between Mmip-2 and mxi1 (not shown).
Co-immunoprecipitation of Mmip2 and mad1
To provide additional and independent evidence for an in vivo interaction between Mmip-2 and mad member proteins, we performed co-immunoprecipitation experiments. An expression vector encoding a myc epitopetagged Mmip-2 protein was co-transfected into Cos-7 cells along with a non-epitope-tagged full-length mad1 expression vector. Two dierent ratios of plasmids were used based on the experiments presented in the preceding section. Two days later, the cells were harvested and the expressed Mmip-2 protein was precipitated from lysates with a monoclonal antibody directed against the myc epitope tag. Precipitates were collected, resolved by SDS ± PAGE and transferred to a PVDF membrane which was then probed in a Western type analysis with a polyclonal anti-mad1 antibody. As seen in Figure 10 , none of the control lanes showed evidence of a protein related to mad1 ( Figure 10 , lanes 1 ± 3). This generally remained true when Mmip-2 and mad 1 plasmids were co-expressed at 1 : 1 molar ratios ( Figure 10 , lane 4). In contrast, when mad1 and Mmip-2 were co-expressed at a 1 : 5 molar ratio, we detected a distinct mad1-speci®c band ( Figure 10 , lane 5). These results are consistent with those presented in the preceding section and indicate that mad1 and Mmip-2 interact most strongly with one another only when they are co-expressed at unequal ratios.
Discussion
Mmip-2 is a novel RING ®nger protein that was identi®ed in a yeast two-hybrid screen by virtue of its ability to interact with mad1, a transcriptional repressor of myc target genes . Mmip-2 also interacts strongly with each of the three other known members of the mad family (Zervos et al., 1993; Hurlin et al., 1995a) but associates only very weakly or not at all with c-myc, max, or several proteins which contain only bHLH or bZIP domains. The functional consequences of the Mmip-2-mad member interaction include the loss of DNA binding by mad-max heterodimers, the restoration of transcriptional potency by c-myc-max heterodimers, and reversal of madmediated inhibition of focus formation by c-myc+ras in primary ®broblasts.
Using the yeast two hybrid assay as an unbiased means for assessing biologically relevant protein : protein interactions, we determined that the interaction with Mmip-2 requires only the ZIP domain of mad1. The ZIP domain of mad proteins is also required for the interaction with Mmip-1, a ZIPcontaining protein bearing no homology to Mmip-2 (Gupta et al., 1998) . That two unrelated proteins should possess similar mechanisms of mad protein interaction suggests that interfering with ZIP dimerization may be a common means of controlling myc network associations.
Similar yeast two-hybrid experiments, performed with a series of N-and C-terminal deletions of Figure 8 Reversal of mad-mediated inhibition of c-myc+ras ± dependent focus formation in primary rat embryo ®broblasts. The indicated DNAs were added to duplicate, 100 mm plates of Fisher rat embryo ®broblasts seeded the previous day at 5610 5 cells/plate. Empty vector DNAs were used to equalize the total amounts of DNA in all transfections. In addition, each plate also received 3 mg of pCMV-CAT as a control for transfection eciency. Two days after transfection, one plate was harvested for a CAT assay while the other was split 1 : 5 and grown in the presence of 5% fetal calf serum until reaching 80 ± 90% con¯uency at which time the serum concentration was reduced to 2% for the remainder of the experiment. Foci were enumerated 14 ± 21 days later and were adjusted for transfection eciencies based on CAT assays (generally 520% among samples). The results shown represent the average numbers of foci for 3 ± 5 independent experiments +1 s.e.
Mmip-2, revealed a more complex requirement for mad protein association. Two regions, one at the Nterminus, immediately adjacent to and possibly overlapping with the RING ®nger, and another at the extreme C-terminus appear to be required for Mmip-2's interaction with mad1. Although the RING ®nger has now been determined to be necessary for protein : protein interactions in a variety of cases (Kim et al., 1996; Bellon et al., 1997; Jensen et al., 1998) , other bona ®de in vivo interactions do not require this motif. These include the associations between the RING ®nger-containing proteins Bmi-1 and dinG/RING1B and the Polyhomeotic protein Mph2 (Hemenway et al., 1998) , the small nuclear RING ®nger protein SNURF and the androgen receptor (Moilanen et al., 1998) , and the formation of a ternary complex between cyclinH-cdk7 and the MAT1 RING ®nger protein (Tassan et al., 1995) . However, while the RING ®nger of Mmip-2 is dispensable for its interaction with mad family members, it seems reasonable to believe that it may function to bind other targets, perhaps as part of a higher order complex in association with mad proteins.
The ®nding that Mmip-2 localizes to a small number of discrete, juxtanuclear foci, and that this pattern is dynamic, is in keeping with the tendency of several other well characterized RING ®nger proteins to display related behaviors. One well known example is seen in the case of PML, a protein that is fused to the retinoic acid receptor (RAR) in the most common, t(15;17), subtype of acute promyelocytic leukemia (Borrow et al., 1990; Longo et al., 1990; deThe et al., 1991) . The nonfusion PML protein normally localizes to large subnuclear particles of distinctly dierent appearance than those formed by the disease-associated PML-RAR protein (Dyck et al., 1994) . Similarly, the BRCA-1 RING-®nger-containing breast and ovarian cancer susceptibility protein localizes to large, discrete nuclear foci in association with the Rad51 and BARD1 proteins (Wu et al., 1996; Scully et al., 1997) . This subnuclear pattern rapidly disperses following DNA damage. Yet another example involves Figure 9 Subcellular localization of Mmip-2 and mad3. Mmip-2 and mad3 were expressed as full-length fusions with the Topaz or Sapphire spectral variants of GFP, respectively, under the control of the CMV immediate-early promoter. Each vector was then transiently transfected into NIH3T3 ®broblasts, either alone or in combination. Nuclei were counterstained with DAPI and the GFPs were imaged by epi¯uorescence microscopy using either`Topaz' or`Sapphire' conditions (see Materials and methods). (a) Cells were transfected with Sapphire-mad3 alone and imaged under Sapphire conditions; (b) The same cell imaged under Topaz conditions; (c) Cells were transfected with Topaz-Mmip-2 and imaged under Topaz conditions; (d) The same cell imaged under Sapphire conditions; (e) Co-transfection with Sapphire-mad3 and Topaz-Mmip-2 at a 1 : 1 molar ratio and imaged under Sapphire conditions. Note that, as in (b), most of the Sapphire-mad3 protein is nuclear; (f) the same cell imaged under Topaz conditions showing that, as in (c), most of the Topaz-Mmip-2 is juxtanuclear; (g) Co-transfection with Sapphire-mad3 and Topaz-Mmip-2 at a 5 : 1 molar ratio and imaged under Sapphire conditions. Sapphire-mad3 is again nuclear; (h) the same cell under Topaz conditions. Note that the Topaz-Mmip-2 is now nuclear. (i) a merged image of (g) and (h). Yellow/orange indicates co-localization of Sapphiremad3 and Topaz-Mmip-2 proteins. (j) Sapphire-mad3 and Topaz-Mmip-2 were co-expressed at a 1 : 5 ratio and imaged under Sapphire conditions. Note that most of the Sapphire-mad3 protein has left the nucleus and now resides in juxtanuclear deposits; (k) The same cell imaged under Topaz conditions. Note that, as before, Topaz-Mmip-2 is also in juxtanuclear despoits; (l) The merged image of (j) and (k) shows that Sapphire-mad3 and Topaz-Mmip-2 co-localize to the juxtanuclear region. Similar patterns of colocalization were observed in both Rat1a and Cos7 cells (not shown) the rag-1 and rag-2 RING ®nger proteins involved in V(D)J recombination and B-lymphocyte development. In cells expressing individual proteins, rag-1 localizes to regions of the nucleus which stain poorly with propidium iodide (`PI holes') whereas rag-2 is excluded from them (Leu and Schatz, 1995). Concurrent expression of the two proteins results in rag-2's co-localization with rag-1 to the PI holes. This suggests that rag-1 and rag-2 either directly or indirectly associate into a common macromolecular complex necessary for the proper biological function of these proteins. Based on these observations, it seems reasonable to suggest that the large juxtanuclear Mmip-2 dots seen in Figure 9 represent a complex multiprotein structure of which Mmip-2 is only one component.
The observation that Mmip-2 and mad3 are codominant ( Figure 9 ) suggests a novel means of regulation for mad member proteins. In actively proliferating or undierentiated cells, which typically contain high levels of c-myc and low levels of mad protein, transcriptional repression by any mad which is expressed might be kept in abeyance by virtue of its association with Mmip-2 and its exclusion from the nucleus. The induction of high mad protein levels, such as occurs during terminal dierentiation (Larsson et al., 1994; Hurlin et al., 1995a,b; Vastrik et al, 1995) , would result in a change in Mmip-2 : mad ratios and the re-entry of mad into the nucleus where it could then serve to repress myc-responsive target genes (Schreiber-Agus and DePinho, 1998). The sequestration of mad proteins in the cytoplasm could also explain how some proliferating cells with high c-myc levels might be able to tolerate the simultaneous expression of mad proteins (Hurlin et al., 1995b) . Why Mmip-2 should enter the nucleus when mad proteins are in excess, and what function it might serve in this capacity is currently unknown.
Materials and methods
Yeast two-hybrid screening and sequencing of Mmip-2 A`bait' vector consisting of the entire bHLH-ZIP domain of mad1 was constructed by amplifying codons 68 ± 140 using the polymerase chain reaction (PCR). Ampli®cation primers consisted of the following sequences: forward: 5'-CGC GAA TTC AGA CGG GCT CAT CTT CGC TTG-3'; reverse: 5'-CGC GGA TCC TTA CCT CTC AAT GCC CAG CTT CTC-3'' where bases in italics indicatè GC' clamps and EcoRI and BamHI restriction sites, respectively, to facilitate directional cloning into EcoRI+BamHI-digested pGBT9. The plasmid was transformed into the Y153 yeast strain as previously described Gupta et al., 1998 ) and a single colony was picked. Expression of a fusion protein between the yeast Gal4 DNA binding domain and the mad1 bHLH-ZIP domain was con®rmed by Western blotting of yeast extracts using a polyclonal antibody against the Gal4 DNA binding moiety as previously described (not shown). That the mad1 bHLH-ZIP domain retained its proper function was con®rmed by demonstrating a strong interaction with a pGAD10`prey' vector expressing a Gal4 activation domain-max fusion to max (Table 1 , line 4). Screening of a d.11 murine embryo cDNA library in the pGAD10 yeast vector was performed as previously described Gupta et al., 1998) . Brie¯y, approximately 4610 6 transformants were plated onto his-, trp-, leu-SC plates containing 20 mg/ml adenine sulfate, 20 mg/ml uracil, and 30 mM 3-aminotriazole (Sigma, St Louis, MO, USA). A total of three histidine prototrophs were strongly positive for b-galactosidase production. Recovery of cDNAs was performed in the JEB 181 E. coli strain as previously described Gupta et al., 1998) . DNA sequence analysis showed that all three cDNAs encoded the same open reading frame. The interaction between each of the proteins encoded by the pGAD vector and the pGBT9-mad1 bait was con®rmed by re-transformation of yeast with the appropriate combinations of vectors (Table 1 , line 5, and data not shown).
A more complete Mmip-2 cDNA was obtained by screening a Friend murine erythroleukemia cDNA library in the lZAP vector (Stratagene, LaJolla, CA, USA) with the pGAD-Mmip-2 cDNA insert. Several hybridizing clones, containing coding region sequence both upstream and downstream of the original cDNA isolate were identi®ed and were used to reconstruct a single cDNA containing the entire coding region. All DNA sequencing was performed on an ABI Model 373 automated DNA sequencer (Applied Biosystems, Inc. Foster City, CA, USA) using an ABI dye terminator cycle sequencing kit according to the supplier's directions.
Yeast expression vectors
The construction of pGBT9-based vectors containing the following fusion proteins have been previously described Gupta et al., 1998) : mxi1 (amino acids 60 ± 160), mad3 (amino acids 48 ± 150), mad4 (amino acids 46 ± 152), max (amino acids 3 ± 160), c-myc (amino acids 362 ± 439), Id1 (73 ± 138), and MyoD (amino acids 83 ± 184). All of the expressed proteins have also been previously Figure 10 Co-immunoprecipitation of Mmip-2 and mad1. Cos-7 cells were transfected with the expression vectors for mad1 or Mmip-2 fused to a c-myc epitope tag at its C-terminus. A control culture (lane 1) was transfected with each of the empty vectors alone. Two days later, cells were harvested, lysed and precipitated with the 9E10 monoclonal antibody directed against the epitope tag. Precipitates were collected, resolved by SDS ± PAGE, electroblotted to a PVDF membrane and subjected to Western analysis using a rabbit polyclonal anti-mad1 antibody. No mad1 protein was detected in the empty vector control sample (lane 1), in either of the samples transfected with only the mad1 or Mmip-2 expression vectors (lanes 2 and 3), or in a mad1 : Mmip-2 cotransfection performed at a 1 : 1 molar ratio (lane 4). In contrast, when mad1 and Mmip-2 were co-expressed at a 1 : 5 ratio, a mad1 signal was readily detected (lane 5) demonstrated to interact speci®cally with previously identi®ed partners (Gupta et al., 1998) . pGBT9-mad1delH1, which removed the basic domain and nearly all of helix 1 from the bHLH domain was constructed by using PCR to amplify mad1 codons 80 ± 140. Similarly, pGBT9-mad1delZIP, which removed most of the ZIP domain, was constructed by using PCR to amplify mad1 codons 68 ± 121. Neither of these proteins was able to interact with a pGAD-max fusion protein in a two-hybrid assay (Table 1 , lines 30 and 32), thus con®rming the need for an intact HLH-ZIP domain.
GST pulldowns
The original Mmip-2 cDNA isolate, encoding amino acids 3 ± 302, was excised from the pGAD10 parental vector and cloned into the pGEX-4T expression vector (Pharmacia, Piscataway, NJ, USA). GST-Mmip-2, or GST alone, was puri®ed to near homogeneity as previously described Gupta et al., 1998) .
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S-methionine-labeled fulllength c-myc, max, mad1, mxi, mad3, and mad4 were synthesized in a coupled in vitro transcription/translation reaction (Promega, Madison, WI, USA) as previously described (Gupta et al., 1998) . Approximately one-quarter of each reaction was incubated with 0.5 mg of GST or GSTMmip-2 and then precipitated by the addition of 30 ml of glutathione-agarose beads. The precipitates were collected by centrifugation and washed three times in wash buer (Gupta et al., 1998) containing 150 ± 350 mM NaCl depending upon the protein combination under study. The ®nal pellets were resuspended and boiled in loading buer, resolved by SDS-12% polyacrylamide gel electrophoresis (SDS ± PAGE) and processed for¯uorography after ®xing the gel in Amplify (Amersham, Bucks, UK). In a separate lane, the same amount of total in vitro translated protein was included to serve as the denominator for the amount of product bound by GST-Mmip-3 or GST alone.
Electrophoretic mobility shift assays (EMSAs)
All proteins except c-myc were expressed as full-length amino terminally-tagged hexahistidine fusions in one of the QE series of bacterial expression vectors (Qiagen, Chatsworth, CA, USA) (Prochownik and VanAntwerp, 1993; Zhang et al., 1997; Gupta et al., 1998; Yin et al., 1998) . In the case of c-myc, amino acids 346 ± 439 were expressed to allow improved solubility of the recombinant product (Prochownik and VanAntwerp, 1993) . All proteins were puri®ed to 490% homogeneity using nickel-agarose anity chromatography as previously described (Prochownik and VanAntwerp, 1993) and were stored in 16 binding buer in small aliquots at 7808C. EMSAs were performed as previously described (Prochownik and VanAntwerp, 1993; Zhang et al., 1997; Yin et al., 1998) using approximately 20 ng of each myc network protein and the indicated amounts of GST or GSTMmip-2. Protein interactions were allowed to proceed at 408C for 20 min prior to the addition of 1 mg of poly(dI):(dC) (Pharmacia) and approximately 0.1 ng of the palindromic, double-stranded E0(GAC) c-myc binding site oligonucleotide (Prochownik and VanAntwerp, 1993) , end-labeled with 32 P-g-ATP (sp. act. 43000 Ci/mmol, Amersham, Arlington, IL, USA) in a standard polynucleotide kinase reaction to a speci®c activity of 3 ± 5610 8 d.p.m./mg. The ®nal volume of all reactions was 20 ml. Following an additional 20 min incubation at room temperature, the reactions were electrophoresed at room temperature on a 4% non-denaturing polyacrylamide gel, dried and processed for autoradiography (Prochownik and VanAntwerp, 1993; Zhang et al., 1997; Yin et al., 1998) .
Cell culture and DNA transfections NIH3T3, Cos-7, HeLa and primary rat embryo ®broblasts were maintained, and DNA transfections were performed, as previously described Gupta et al., 1998) . For transient transfections, the following plasmid DNAs were used: pSVLneo-c-myc, pSVLneo-max (160 amino acid isoform) (Zhang et al., 1997) , and pRcCMV (Invitrogen) containing full-length cDNAs for mad1, mxi1, mad3, or mad4 (Zhang et al., 1997; Gupta et al., 1998; Yin et al., 1998) . Mmip-2 was expressed in the pSVLneo vector after altering its initiator ATG so as to conform better to a consensus Kozak site (GCA ATG G?ACA ATG G). The region between nt 124 and 1087, containing the entire coding region of Mmip-2 (Figure 2 ), was ampli®ed with primers containing unique XhoI restriction sites, digested with XhoI and cloned into the XhoI site of the vector. The correct structure of the resultant construct was con®rmed by restriction mapping and DNA sequencing. Reporter constructs consisted of ODC-CAT or p3xMycE1bLuc (Gupta et al., 1993; Packham and Cleveland, 1994) . Each transfection mix also contained 3 mg of pCMVbGal to allow for normalization of transfection eciencies (Zhang et al., 1997) . All plasmid DNAs were puri®ed using Qiagen columns. Transfections were performed at least three times in duplicate plates using a calcium phosphate-based procedure. b-galactosidase, luciferase, and CAT assays were performed as previously described (Zhang et al., 1997; Gupta et al., 1998; Yin et al., 1998) . Focus formation assays in primary rat embryo ®broblasts were performed with Lipofectamine (GIBCO ± BRL, Grand Island, NY, USA) as previously described (Gupta et al., 1998) .
Mammalian two-hybrid assays
The original Mmip-2 cDNA isolate (codons 3 ± 302) was excised from the parental pGAD10 vector and recloned into the pSG424 mammalian two-hybrid vector (Finkel et al., 1993) . The resultant vector (pSG424-Mmip-2) encodes a fusion protein consisting of the Gal4 DNA binding domain and the nearly full-length Mmip2. The plasmid pNLVP (Finkel et al., 1993) was used to create a fusion between the VP16 transactivation domain and full-length mad1 or mxi1. Transient transfections were performed in HeLa cells as previously described using the pGal5E472CAT reporter plasmid . 3 mg of the pCMV-b-gal plasmid (Clontech, Palo Alto, CA, USA) was included as an internal control for transfection eciencies.
Northern blotting
To determine the size of the endogenous Mmip-2 transcript, total RNA (10 mg/lane) was electrophoresed in a 1% agaroseformaldehyde gel and transferred to a Nytran membrane (Schleicher and Schuell, Keene, NH, USA). The blot was hybridized sequentially with a 32 P-labeled cDNA containing the entire coding region of Mmip-2 under standard conditions and a cDNA encoding murine a-actin. To determine the tissue distribution of Mmip-2, a`Mouse RNA Master Blot' (Clontech), containing 2 mg of`dotblotted' poly(A) + RNA from 18 dierent adult murine tissues and total embryos of four dierent gestational ages was also hybridized with the Mmip-2 cDNA probe. Blots were exposed to BioMax MS X-ray ®lm (Kodak, Rochester, NY, USA) with an intensifying screen at 7808C for 4 h ± 3 days.
Subcellular localization
Two spectral variants of green¯uorescent protein (GFP) termed`Topaz' and`Sapphire' (Packard Instruments) were used to study the interaction between Mmip-2 and mad3. The excitation/emission maxima for the proteins (Topaz=514 nm/527 nm; Sapphire=395 nm/510 nm) are such that they can each be separately identi®ed without signi®cant interference from the other, thus making them of utility in co-expression studies. To construct mammalian expression vectors, the cDNAs for each GFP variant were ampli®ed by PCR using the following primers: forward: 5'-CGC GCT AGC ACC ATG GTG AGC AAG GGC GAG GA-3' where the italics indicate a`GC clamp' and an NheI restriction site, and the underlined region represents an optimized Kozak element-translation initiation site; reverse: 5'-CGC AGA TCT CTT GTA CAG CTC GTC CAT GCC-3' where the italics again indicate a GC clamp and a BglII restriction and the underlined sequence indicates the codon of the last amino acid in the GFP protein. After digestion of the ampli®ed fragments with NheI and BglII and puri®cation by agarose gel electrophoresis, they were used to replace wild-type GFP coding sequences in the pEGFP-C1 mammalian expression vector (Clontech). The plasmid containing Topaz sequences was next next digested with SalI to allow for ligation of a full-length Mmip-2 cDNA excised from the pSVLneo-Mmip-2 expression vector with XhoI. This fragment contains 6 bp of 5' untranslated region derived from the original Mmip-2 cDNA and thus introduces only two amino acids between the end of GFP and the beginning of Mmip-2. This vector was designated pTopaz-Mmip-2 Similarly, a PCR-ampli®ed cDNA fragment containing the entire coding region of mad3 and 6 bp of 5'-untranslated region was ligated into the Sal site of the Sapphire expression vector to create pSapphire-mad3. The identity, orientation and reading frame of each plasmid was con®rmed by DNA sequencing using a GFP primer. Western blots of lysates from transiently transfected Cos7 cells were probed with an anti-GFP monoclonal antibody (Clontech) to verify the expression of Topaz-Mmip-2 and Sapphire-mad3 fusion proteins of the predicted size (not shown). Each of the above plasmids was then introduced, either individually or in combination, and at dierent molar ratios, into NIH3T3 cells using Lipofectamine (GIBCO ± BRL). The cells had been plated the day before onto glass coverslips in 6 well tissue culture plates. Following a 3 h application of the DNA-Lipofectamine mixture to cells in serum-free medium, an equivalent volume of fresh medium containing 20% supplemented calf serum (GIBCO ± BRL) was added to the cells for an additional 3 ± 4 h. Cells were ®xed in 2%-paraformaldehyde-PBS prior to viewing by epi¯uorescence microscopy. For this we used a Nikon Diaphot inverted microscope equipped with an attenuated xenon arc lamp, a cooled CCD camera and a Sutter Lambda 10-2 ®lter wheel for changing excitation ®lters (400+20 nm for Sapphire, 505+5 nm for Topaz, and 340+nm for DAPI). A 535+25 nm emission ®lter was used for imaging GFPtagged proteins while a 480+30 nm emission ®lter was used for imaging DAPI-labeled nuclei.
Co-immunoprecipitation experiments
Standard PCR techniques were used to amplify the complete coding sequence of Mmip-2 minus the termination codon.
This fragment was cloned into the pSVLneo-myc tag vector so that the Mmip-2 coding region was in-frame with the cmyc epitope, EQKLISQQDL. Transfection of Cos-7 cells with this vector con®rmed the production of an appropriately sized myc-tagged Mmip-2 protein that was easily detected by Western blotting using the 9E10 monoclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) (not shown). For co-immunoprecipitation studies, 5 mg of the above vector, either alone or together with the indicated amounts of pSVLneo-mad1 were co-transfected into Cos-7 cells using a standard calcium phosphate transfection protocol (Gupta et al., 1998) . Two days later, cells were washed twice in phosphate-buered saline (PBS) and then lysed in 1 ml of PBS-1% NP-40 containing Complete 1 protease inhibitor cocktail (Boehringer-Mannheim, Indianapolis, IN, USA) at the concentration recommended by the supplier. After clearing of the lysate by centrifugation (10 000 g for 10 min), 0.5 ml was precipitated by the addition of 9E10 antibody to a ®nal dilution of 1 : 1000 After overnight incubation at 48C, antigen-antibody complexes were precipitated by the addition of 40 ml Staph A protein-agarose beads (BioRad, Hercules, CA, USA) for an additional 2 h at room temperature. Precipitates were collected by centrifugation, washed ®ve times in PBS-1%NP-40, boiled in standard SDS ± PAGE lysis buer, and resolved by SDS ± PAGE. The gel was then electroblotted to a PVDF membrane as previously described . The blot was incubated with a 1 : 500 dilution of a rabbit polyclonal anti-mad1 antibody that had been raised against the full-length hexahistidine fusion protein described above. Blocking was performed in PBS-T containing 5% non-fat dried milk . Following extensive washing and incubation with a second horseradish peroxidase-labeled goat-anti rabbit secondary antibody, the blot was developed using a chemiluminescence kit (Renaissance, New England Nuclear, Boston, MA, USA) according to the supplier's recommendations.
Note added in proof
The sequence of MMIP-2 has been deposited with GenBank (Accession no. AF190166).
